EP3432887
Berklalyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.3.2017EP published:
2.9.2020EP application number:
17710980.8
EP translation filed:
12.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
19.3.2037Expiry date:
19.3.2027Next due date:
31.3.2027
Title:
ANTITUBERCULOSIS AGENT
Timeline
Today
20.3.2017EP application
2.9.2020EP Publication
12.11.2020Translation submitted
15.12.2020Registration published
19.3.2027Expires
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
BALLELL PAGES, LluisAddress:
28760 Madrid, ES
Name:
BARROS AGUIRRE, DavidAddress:
28760 Madrid, ES
Name:
BATES, Robert HAddress:
28760 Madrid, ES
Name:
CASTRO PICHEL, JuliaAddress:
28760 Madrid, ES
Name:
ESQUIVIAS PROVENCIO, JorgeAddress:
28760 Madrid, ES
Name:
PETHE, KevinAddress:
Singapore 636921, SG
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16382124Date:
22.3.2016Country:
EP
Classification
Categories:
A61K 31/513, C07D 239/54, C07D 401/06, A61P 31/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.2.2021
Expires: 19.3.2022
Payer: Örn Þór slf.
Number: 6
Paid: 17.2.2022
Expires: 19.3.2023
Payer: Patice ehf.
Number: 7
Paid: 22.2.2023
Expires: 19.3.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.3.2024
Expires: 19.3.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.3.2025
Expires: 19.3.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 20.3.2026
Expires: 19.3.2027
Payer: Árnason Faktor ehf.